Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2012, Article ID 301274, 6 pages
http://dx.doi.org/10.1155/2012/301274
Review Article

Neonatal Lupus Erythematosus

1Department of Pediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, 6/F, Clinical Sciences Building, Shatin, Hong Kong
2Department of Pediatrics, Alberta Children’s Hospital, The University of Calgary, Calgary, AB, Canada T2N 1N4

Received 4 June 2012; Revised 29 July 2012; Accepted 2 August 2012

Academic Editor: Hiroshi Okamoto

Copyright © 2012 Kam Lun Hon and Alexander K. C. Leung. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Garcia and A. C. Campos-de-Carvalho, “Neonatal lupus syndrome: the heart as a target of the immune system,” Anais da Academia Brasileira de Ciencias, vol. 72, no. 1, pp. 83–89, 2000. View at Google Scholar · View at Scopus
  2. L. K. Hornberger and N. Al Rajaa, “Spectrum of cardiac involvement in neonatal lupus,” Scandinavian Journal of Immunology, vol. 72, no. 3, pp. 189–197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. F. Perez, M. E. de Torres, M. M. Buján, A. Lanoël, A. B. Cervini, and A. M. Pierini, “Neonatal lupus erythematosus: a report of four cases,” Anais Brasileiros de Dermatologia, vol. 86, no. 2, pp. 347–351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. H. McCuistion and E. P. Schoch Jr., “Possible discoid lupus erythematosus in newborn infant: report of a case with subsequent development of acute systemic lupus erythematosus in mother,” AMA Archives of Dermatology and Syphilology, vol. 70, no. 6, pp. 782–785, 1954. View at Publisher · View at Google Scholar · View at Scopus
  5. J. P. Buyon and R. M. Clancy, “Neonatal lupus syndromes,” Current Opinion in Rheumatology, vol. 15, no. 5, pp. 535–541, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Ayed, Y. Gorgi, I. Sfar, and M. Khrouf, “Congenital heart block associated with maternal anti SSA/SSB antibodies: a report of four cases,” Pathologie Biologie, vol. 52, no. 3, pp. 138–147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Li, G. F. Dong, F. Z. Han, Y. Cui, Y. Z. Shi, and X. Zhang, “Neonatal lupus erythematosus: a report of 7 cases and review of 87 cases of China,” Zhonghua Er Ke Za Zhi, vol. 49, pp. 146–150, 2011. View at Google Scholar
  8. M. Shahian, A. Khosravi, and M. H. Anbardar, “Early cholestasis in neonatal lupus erythematosus,” Annals of Saudi Medicine, vol. 31, no. 1, pp. 80–82, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Eftekhari, L. Salle, F. Lezoualc'h et al., “Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block,” European Journal of Immunology, vol. 30, pp. 2782–2790, 2000. View at Google Scholar
  10. W. Wisuthsarewong, J. Soongswang, and R. Chantorn, “Neonatal lupus erythematosus: clinical character, investigation, and outcome,” Pediatric Dermatology, vol. 28, no. 2, pp. 115–121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Boutjdir, L. Chen, Z. H. Zhang, C. E. Tseng, N. El-Sherif, and J. P. Buyon, “Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model,” Pediatric Research, vol. 44, no. 1, pp. 11–19, 1998. View at Google Scholar · View at Scopus
  12. J. P. Buyon, “Neonatal lupus: bedside to bench and back,” Scandinavian Journal of Rheumatology, vol. 25, no. 5, pp. 271–276, 1996. View at Google Scholar · View at Scopus
  13. E. Jaeggi, C. Laskin, R. Hamilton, J. Kingdom, and E. Silverman, “The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus. A Prospective Study of 186 antibody-exposed fetuses and infants,” Journal of the American College of Cardiology, vol. 55, no. 24, pp. 2778–2784, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Okawa-Takatsuji, S. Aotsuka, S. Uwatoko et al., “Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases,” Clinical and Experimental Immunology, vol. 126, no. 2, pp. 345–354, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Miranda-Carus, A. D. Askanase, R. M. Clancy et al., “Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-α by macrophages,” Journal of Immunology, vol. 165, no. 9, pp. 5345–5351, 2000. View at Google Scholar · View at Scopus
  16. J. Liu, Y. H. Yang, Y. T. Lin, and B. L. Chiang, “Clinical characteristics of neonatal lupus erythematosus,” Journal of Microbiology, Immunology and Infection, vol. 34, no. 4, pp. 265–268, 2001. View at Google Scholar · View at Scopus
  17. P. H. Schur, I. Meyer, M. Garovoy, and C. B. Carpenter, “Associations between systemic lupus erythematosus and the major histocompatibility complex: clinical and immunological considerations,” Clinical Immunology and Immunopathology, vol. 24, no. 2, pp. 263–275, 1982. View at Google Scholar · View at Scopus
  18. S. Miyagawa, K. Shinohara, T. Fujita et al., “Neonatal lupus erythematosus: analysis of HLA class II alleles in mothers and siblings from seven Japanese families,” Journal of the American Academy of Dermatology, vol. 36, no. 2, part 1, pp. 186–190, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. P. M. Izmirly, A. Saxena, M. Y. Kim et al., “Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus,” Circulation, vol. 124, pp. 1927–1935, 2011. View at Google Scholar
  20. S. Miyagawa, “Neonatal lupus erythematosus: a review of the racial differences and similarities in clinical, serological and immunogenetic features of Japanese versus Caucasian patients,” Journal of Dermatology, vol. 32, no. 7, pp. 514–522, 2005. View at Google Scholar · View at Scopus
  21. J. P. Buyon, R. Hiebert, J. Copel et al., “Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry,” Journal of the American College of Cardiology, vol. 31, no. 7, pp. 1658–1666, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. A. R. Neiman, L. A. Lee, W. L. Weston, and J. P. Buyon, “Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry,” Journal of Pediatrics, vol. 137, no. 5, pp. 674–680, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Spence, L. Hornberger, R. Hamilton, and E. D. Silverman, “Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and/or anti-La antibodies,” Journal of Rheumatology, vol. 33, no. 1, pp. 167–170, 2006. View at Google Scholar · View at Scopus
  24. A. Brucato, M. Frassi, F. Franceschini et al., “Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women,” Arthritis & Rheumatism, vol. 44, pp. 1832–1835, 2001. View at Google Scholar
  25. E. Silverman and E. Jaeggi, “Non-cardiac manifestations of neonatal lupus erythematosus,” Scandinavian Journal of Immunology, vol. 72, no. 3, pp. 223–225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. L. A. Lee, “Cutaneous lupus in infancy and childhood,” Lupus, vol. 19, no. 9, pp. 1112–1117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Lynn Cheng, S. Galbraith, and K. Holland, “Congenital lupus erythematosus presenting at birth with widespread erosions, pancytopenia, and subsequent hepatobiliary disease,” Pediatric Dermatology, vol. 27, no. 1, pp. 109–111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Penate, D. Lujan, J. Rodriguez et al., “Neonatal lupus erythematosus: 4 cases and clinical review,” Actas Dermosifiliogr, vol. 96, pp. 690–696, 2005. View at Google Scholar
  29. D. Elish and N. B. Silverberg, “Neonatal lupus erythematosus,” Cutis, vol. 77, no. 2, pp. 82–86, 2006. View at Google Scholar · View at Scopus
  30. R. Cimaz, M. Biggioggero, L. Catelli, S. Muratori, and S. Cambiaghi, “Ultraviolet light exposure is not a requirement for the development of cutaneous neonatal lupus,” Lupus, vol. 11, no. 4, pp. 257–260, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. P. M. Izmirly, C. Llanos, L. A. Lee, A. Askanase, M. Y. Kim, and J. P. Buyon, “Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block,” Arthritis and Rheumatism, vol. 62, no. 4, pp. 1153–1157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Guettrot-Imbert, L. Cohen, L. Fermont et al., “A new presentation of neonatal lupus: 5 Cases of isolated mild endocardial fibroelastosis associated with maternal anti-SSA/Ro and anti-SSB/La antibodies,” Journal of Rheumatology, vol. 38, no. 2, pp. 378–386, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. Boros, D. Spence, S. Blaser, and E. D. Silverman, “Hydrocephalus and macrocephaly: new manifestations of neonatal lupus erythematosus.,” Arthritis and Rheumatism, vol. 57, no. 2, pp. 261–266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. Q. Yang, X. M. Shao, Y. Cao et al., “Neonatal lupus erythematosus: analysis of 8 cases,” Zhonghua er Ke Za Zhi, vol. 46, no. 1, pp. 18–21, 2008. View at Google Scholar · View at Scopus
  35. V. Martin, L. A. Lee, A. D. Askanase, M. Katholi, and J. P. Buyon, “Long-term followup of children with neonatal lupus and their unaffected siblings,” Arthritis and Rheumatism, vol. 46, no. 9, pp. 2377–2383, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Sun, T. M. Yuan, L. H. Chen, and H. M. Yu, “Neonatal lupus erythematosus: three case reports and review of the chinese literature,” Clinical Pediatrics, vol. 49, no. 7, pp. 627–634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. A. Akin, A. Baykan, S. Sezer, and T. Gunes, “Review of literature for the striking clinic picture seen in two infants of mothers with systemic lupus erythematosus,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 24, no. 8, pp. 1022–1026, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Brucato, A. Doria, M. Frassi et al., “Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study,” Lupus, vol. 11, no. 11, pp. 716–721, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. C. H. Yang, J. Y. Chen, S. C. Lee, and S. F. Luo, “Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjögren's syndrome A/Ro antibody,” Journal of Microbiology, Immunology and Infection, vol. 38, no. 5, pp. 365–369, 2005. View at Google Scholar · View at Scopus
  40. J. P. Buyon, R. M. Clancy, and D. M. Friedman, “Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside,” Nature Clinical Practice Rheumatology, vol. 5, no. 3, pp. 139–148, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. D. M. Friedman, C. Llanos, P. M. Izmirly et al., “Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial,” Arthritis and Rheumatism, vol. 62, no. 4, pp. 1138–1146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. C. N. Pisoni, A. Brucato, A. Ruffatti et al., “Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study,” Arthritis and Rheumatism, vol. 62, no. 4, pp. 1147–1152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. P. M. Izmirly, M. Y. Kim, C. Llanos et al., “Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine,” Annals of the Rheumatic Diseases, vol. 69, no. 10, pp. 1827–1830, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Shinohara, S. Miyagawa, T. Fujita, T. Aono, and K. I. Kldoguchi, “Neonatal lupus erythematosus: results of maternal corticosteroid therapy,” Obstetrics and Gynecology, vol. 93, no. 6, pp. 952–957, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Tincani, C. B. Rebaioli, M. Frassi et al., “Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome,” Autoimmunity Reviews, vol. 4, no. 7, pp. 423–428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. O. Baud, L. Foix-L'Helias, M. Kaminski et al., “Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants,” The New England Journal of Medicine, vol. 341, no. 16, pp. 1190–1196, 1999. View at Publisher · View at Google Scholar · View at Scopus